Secondary Logo

Journal Logo

Institutional members access full text with Ovid®

Current treatment of older patients with recurrent gynecologic cancer

Yoshida, Yoshio

Current Opinion in Obstetrics and Gynecology: April 4, 2019 - Volume Publish Ahead of Print - Issue - p
doi: 10.1097/GCO.0000000000000543
REVIEW: PDF Only
Buy
PAP

Purpose of review Gynecologic cancer patients of elderly has been increasing rapidly. Useful information on older patients, especially, with recurrent gynecological cancer is extremely limited.

Recent findings A unified concept for assessing treatment risk was proposed when providing cancer treatment to older patients. Fit: patients capable of withstanding the same standard treatment as healthy younger patients; Vulnerable: patients incapable of withstanding the same standard treatment as healthy younger patients, but capable of undergoing some sort of treatment; and Frail: patients incapable of withstanding the same standard treatment as healthy younger patients, and also unsuitable to undergo any kind of active treatment.

It is important to identify vulnerability by using geriatric assessment as a patient background factor, to intervene if treatment is required, and to modify the intensity of treatment in an attempt to extend overall survival, decrease adverse events, improve health-related quality of life, and reduce medical costs.

Summary It is important to carry out a pretreatment functional assessment of older cancer patients using the geriatric assessment, and to choose the method of treatment for older patients in light of its results with recurrent gynecological cancer in addition to chronological age.

Department of Obstetrics and Gynecology, Faculty of Medical Sciences, University of Fukui, Fukui, Japan

Correspondence to Yoshio Yoshida, MD, Department of Obstetrics and Gynecology, University of Fukui, 23-3 Matsuoka-Shimoaizuki, Eiheiji-cho, Yoshida-gun, Fukui 910-1193, Japan. Tel: +81 776 61 3111; fax: +81 776 61 8117; e-mail: yyoshida@u-fukui.ac.jp

Copyright © 2019 YEAR Wolters Kluwer Health, Inc. All rights reserved.